Similar articles for PMID: 26903550

Year	Number of Results
2000	1
2002	2
2003	1
2004	1
2005	4
2006	6
2007	3
2008	7
2009	12
2010	6
2011	7
2012	5
2013	8
2014	9
2015	8
2016	12
2017	7
2018	11
2019	9
2020	12
2021	9
2022	1
2024	0

1

What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?

Muhammad A, van der Lely AJ, O'Connor RD, Delhanty PJ, Dal J, Dallenga AH, Feelders RA, Janssen JA, Jorgensen JO, Neggers SJ. Muhammad A, et al. Eur J Endocrinol. 2016 May;174(5):663-7. doi: 10.1530/EJE-15-1150. Epub 2016 Feb 22. Eur J Endocrinol. 2016. PMID: 26903550

2

Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3.

Franck SE, van der Lely AJ, Delhanty PJ, Jørgensen JO, Neggers SJ. Franck SE, et al. Eur J Endocrinol. 2015 Nov;173(5):553-61. doi: 10.1530/EJE-15-0519. Epub 2015 Aug 4. Eur J Endocrinol. 2015. PMID: 26243033

3

Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly.

Neggers SJ, Franck SE, de Rooij FW, Dallenga AH, Poublon RM, Feelders RA, Janssen JA, Buchfelder M, Hofland LJ, Jørgensen JO, van der Lely AJ. Neggers SJ, et al. J Clin Endocrinol Metab. 2014 Oct;99(10):3644-52. doi: 10.1210/jc.2014-2032. Epub 2014 Jun 17. J Clin Endocrinol Metab. 2014. PMID: 24937542 Clinical Trial.

4

Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study).

Muhammad A, van der Lely AJ, Delhanty PJD, Dallenga AHG, Haitsma IK, Janssen JAMJL, Neggers SJCMM. Muhammad A, et al. J Clin Endocrinol Metab. 2018 Feb 1;103(2):586-595. doi: 10.1210/jc.2017-02017. J Clin Endocrinol Metab. 2018. PMID: 29155991 Clinical Trial.

5

A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues.

Franck SE, Korevaar TIM, Petrossians P, Daly AF, Chanson P, Jaffrain-Réa ML, Brue T, Stalla GK, Carvalho D, Colao A, Hána V, Delemer B, Fajardo C, van der Lely AJ, Beckers A, Neggers SJCMM. Franck SE, et al. Eur J Endocrinol. 2017 Apr;176(4):421-431. doi: 10.1530/EJE-16-0956. Epub 2017 Jan 18. Eur J Endocrinol. 2017. PMID: 28100630 Free article.

6

Combined treatment of somatostatin analogues with pegvisomant in acromegaly.

Franck SE, Muhammad A, van der Lely AJ, Neggers SJ. Franck SE, et al. Endocrine. 2016 May;52(2):206-13. doi: 10.1007/s12020-015-0810-8. Epub 2015 Dec 10. Endocrine. 2016. PMID: 26661938 Free PMC article. Review.

7

Pegvisomant in acromegaly: a multicenter real-life study in Argentina.

Basavilbaso NXG, Ballarino MC, Bruera D, Bruno OD, Chervin AB, Danilowicz K, Fainstein-Day P, Fidalgo SG, Frigeri A, Glerean M, Guelman R, Isaac G, Katz DA, Knoblovits P, Librandi F, Montes ML, Mallea-Gil MS, Manavela M, Mereshian P, Moncet D, Pignatta A, Rogozinsky A, Sago LR, Servidio M, Spezzi M, Stalldecker G, Tkatch J, Vitale NM, Guitelman M. Basavilbaso NXG, et al. Arch Endocrinol Metab. 2019 Aug 22;63(4):320-327. doi: 10.20945/2359-3997000000160. Arch Endocrinol Metab. 2019. PMID: 31460622 Free PMC article.

8

Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone.

van der Lely AJ, Bernabeu I, Cap J, Caron P, Colao A, Marek J, Neggers S, Birman P. van der Lely AJ, et al. Eur J Endocrinol. 2011 Mar;164(3):325-33. doi: 10.1530/EJE-10-0867. Epub 2010 Dec 10. Eur J Endocrinol. 2011. PMID: 21148630 Clinical Trial.

9

Successful use of weekly pegvisomant administration in patients with acromegaly.

Higham CE, Thomas JD, Bidlingmaier M, Drake WM, Trainer PJ. Higham CE, et al. Eur J Endocrinol. 2009 Jul;161(1):21-5. doi: 10.1530/EJE-08-0990. Epub 2009 May 1. Eur J Endocrinol. 2009. PMID: 19411301 Clinical Trial.

10

Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study.

Puig-Domingo M, Soto A, Venegas E, Vilchez R, Blanco C, Cordido F, Lucas T, Marazuela M, Casany R, Cuatrecasas G, Fajardo C, Gálvez MÁ, Maraver S, Martín T, Romero E, Paja M, Picó A, Bernabeu I, Resmini E; ACROCOMB study group. Puig-Domingo M, et al. Endocrinol Nutr. 2016 Oct;63(8):397-408. doi: 10.1016/j.endonu.2016.05.010. Epub 2016 Jul 20. Endocrinol Nutr. 2016. PMID: 27448708 Free article. English, Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

115 results

Results by year